Status:
COMPLETED
Comparison of 25-hydroxy Vitamin D Level in Caucasian Women Receiving Vitamin D Supplementation and Not Receiving Supplementation: a Randomized Controlled Trial.
Lead Sponsor:
Northwestern University
Conditions:
Vitamin D Deficiency
Eligibility:
FEMALE
18-47 years
Phase:
NA
Brief Summary
The objective of this study is to assess whether vitamin D supplements are sufficient to increase females who are deficient or borderline deficient in vitamin D levels to normal levels.
Eligibility Criteria
Inclusion
- Premenopausal Caucasian women, ages 18-47
- Subjects in good health
- Tanning bed group: regular tanning bed user at least once a week for previous 10 weeks
Exclusion
- Pregnancy and lactation
- Subjects with liver disease, renal disease, multiple myeloma, parathyroid disease, irritable bowel disease, celiac disease, cystic fibrosis and pancreatic disease
- Subjects with hypocholesterolemia and primary hyperparathyroidism
- Subjects taking the following medications:
- Steroids
- Orlistat
- Lipid lowering medication: cholestyramine, statins
- Antiepileptic drugs: phenobarbital and phenytoin
- Currently on vitamin D supplements or using any medication contain vitamin D i.e. cod liver oil, topical calcipotriol or history of use within 1 month
- Rifampicin, isoniazid
- Ketoconazole
- Subjects currently on UV therapy
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT00882505
Start Date
April 1 2009
End Date
August 1 2010
Last Update
December 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, United States, 60611